LDR Holding Corp CEO Sells $700,000 in Stock (LDRH)
LDR Holding Corp (NASDAQ:LDRH) CEO Christophe Lavigne sold 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $28.00, for a total transaction of $700,000.00. Following the sale, the chief executive officer now directly owns 983,827 shares in the company, valued at approximately $27,547,156. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of LDR Holding Corp (NASDAQ:LDRH) traded up 0.82% on Tuesday, hitting $28.13. The stock had a trading volume of 154,207 shares. LDR Holding Corp has a 52-week low of $17.79 and a 52-week high of $40.39. The stock has a 50-day moving average of $24.12 and a 200-day moving average of $26.74. The company’s market cap is $730.4 million.
LDR Holding Corp (NASDAQ:LDRH) last released its earnings data on Wednesday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.05. The company had revenue of $34.80 million for the quarter, compared to the consensus estimate of $31.14 million. The company’s revenue for the quarter was up 30.8% on a year-over-year basis. On average, analysts predict that LDR Holding Corp will post $-0.65 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Piper Jaffray raised their price target on shares of LDR Holding Corp from $38.00 to $40.00 in a research note on Thursday, August 7th. They now have an “overweight” rating on the stock. Analysts at RBC Capital initiated coverage on shares of LDR Holding Corp in a research note on Monday, June 23rd. They set an “outperform” rating and a $34.00 price target on the stock. Five investment analysts have rated the stock with a buy rating, LDR Holding Corp has a consensus rating of “Buy” and an average price target of $35.50.
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and surgical technologies for the treatment of patients suffering from spine disorders.
Receive News & Ratings for LDR Holding Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDR Holding Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.